Live feed
Filing
SC 13G
SC 13G0001144204-16-079270·Foresite Capital Fund II, L.P.
Schedule 13G ownership disclosure
Regulus Therapeutics Inc.
Security class unavailable · CUSIP: 75915K101
Event date: 2016-01-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,859,717
- Percent of class
- 3.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-079270
- Form type
- SC 13G
- Filer
- Foresite Capital Fund II, L.P.
- CIK
- CIK 1594914
- Filed
- Feb 05, 2016
- Reporting period
- Jan 28, 2016
- Description
- Schedule 13G beneficial ownership